The University of Arizona Division of Nephrology will host a Special Conference for visiting international scholar José Ibeas López, MD, PhD, a nephrology consultant with Spain’s Hospital de Sabadell–Parc Taulí, which is affiliated with the Universitat Autònoma de Barcelona (UAB), and president elect of the Vascular Access Society, which is based in Maastricht, Netherlands.
The lecture is this Friday, July 14, 1-2 p.m. in the UA College of Medicine – Tucson, Room 5403, where the UA Department of Medicine Grand Rounds are held.
Dr. Ibeas’ will speak on chronic kidney disease and end-stage renal disease under the topic, “CKD and ESRD in Spain: Challenges and Opportunities.” To view, download, post and share the flyer, 
click here [PDF].
He is a graduate in medicine and surgery from the Faculty of Medicine of the Universidad de Alicante (Alicante, Spain), and earned his medical degree from the Universitat Autònoma de Barcelona. His training as a nephrologist was at La Fundació Puigvert y el Hospital de San Pablo (also known as Hospital de la Santa Creu i Sant Pau, UAB), Barcelona. In addition, he holds a master’s degree in evidence-based medicine from the Centro Cochrane Iberoamericano-Hospital de San Pablo, Barcelona. He is currently a consultant in the Nephrology Department of the Hospital de Sabadell, which is part of Barcelona’s Corporació Sanitària Parc Taulí, Barcelona. The Institut Universitari Fundació Parc Taulí—which provides support for all teaching activities and research projects there—also forms part of the Universitat Autònoma de Barcelona.
Dr. Ibeas is widely published, serves on many committees and organizations, and has been an invited speaker at numerous national and international conferences and symposia related to vascular access in hemodialysis for sufferers of advanced kidney disease. This includes being co-chair of the Ninth Congress of the Vascular Access Society, chair of the Work Group for Clinical Guidelines on Vascular Access, secretary of the Vascular Access Working Group for the Spanish Society of Nephrology, and a member in the Clinical Practice Guide on Chronic Renal Disease Group of the Spanish National Health System, International Committee of the American Society of Diagnostic and Interventional Nephrology, and the European Vascular Access Guidelines Group of the European Renal Association-European Dialysis and Transplant Association.
The main areas of his current research interests focus on the study of biomarkers in various areas of the kidney patient with advanced renal failure and hemodialysis, emphasizing those related to inflammation, immunity, early biomarkers of infection, bio-impedance and in particular to vascular access. It is in this last field, vascular access, where he has spent most of his activity in recent years with respect to interventional nephrology. All this activity has led to the development of the Vascular Access Program at the Hospital de Sabadell–Parc Taulí (http://www.tauli.cat/vap).
Questions? Please contact Sharon Bolin, (520) 626-6371, sbolin@deptofmed.arizona.edu